User profiles for Graham Simmons

Graham Simmons

Senior Investigator, Vitalant Research Institute
Verified email at vitalant.org
Cited by 17142

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist

G Simmons, PR Clapham, L Picard, RE Offord… - Science, 1997 - science.org
The chemokine receptors CXCR4 and CCR5 have recently been shown to act as coreceptors,
in concert with CD4, for human immunodeficiency virus–type 1 (HIV-1) infection. RANTES …

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia… - Proceedings of the …, 2005 - National Acad Sciences
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-CoV),
for which there is currently no effective treatment. SARS-CoV mediates receptor binding …

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

G Simmons, JD Reeves… - Proceedings of the …, 2004 - National Acad Sciences
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is a rapidly emerging
pathogen with potentially serious consequences for public health. Here we describe …

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry

G Simmons, D Wilkinson, JD Reeves… - Journal of …, 1996 - Am Soc Microbiol
A panel of primary syncytium-inducing (SI) human immunodeficiency virus type 1 isolates that
infected several CD4+ T-cell lines, including MT-2 and C8166, were tested for infection of …

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells

G Simmons, JD Reeves, CC Grogan… - Virology, 2003 - Elsevier
Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is
found in most tissues and organs during the latter stages of infection. In contrast, a more …

Protease inhibitors targeting coronavirus and filovirus entry

…, S Pöhlmann, JH McKerrow, AR Renslo, G Simmons - Antiviral research, 2015 - Elsevier
In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and
the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by …

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus

TN Kledal, MM Rosenkilde, F Coulin, G Simmons… - Science, 1997 - science.org
Kaposi's sarcoma–associated herpesvirus encodes a chemokine called vMIP-II. This protein
displayed a broader spectrum of receptor activities than any mammalian chemokine as it …

Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63

…, S Pfefferle, I Steffen, MO Muench, G Simmons… - Journal of …, 2010 - Am Soc Microbiol
The human coronaviruses (CoVs) severe acute respiratory syndrome (SARS)-CoV and
NL63 employ angiotensin-converting enzyme 2 (ACE2) for cell entry. It was shown that …

Estimated US infection-and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021

…, ME Patton, B Custer, P Williamson, G Simmons… - Jama, 2021 - jamanetwork.com
Importance People who have been infected with or vaccinated against SARS-CoV-2 have
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 …

Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research

G Simmons, P Zmora, S Gierer, A Heurich, S Pöhlmann - Antiviral research, 2013 - Elsevier
The severe acute respiratory syndrome (SARS) pandemic revealed that zoonotic transmission
of animal coronaviruses (CoV) to humans poses a significant threat to public health and …